Description
by Neelesh Kumar Mehra PhD (ed.)
It also discusses cutting-edge research in reverse engineering approaches, the significance of Quality by Design (QbD), and the treatment of eye-related diseases like glaucoma, age-related macular degeneration, uveal melanoma, cataracts, and fungal keratitis. Corporate researchers will find the manufacturing insights particularly beneficial, making this an essential resource for professionals in the field of ophthalmic drug delivery.
- Combines fundamental concepts, theory, and cases of formulations to manage of eye-related diseases
- Focuses on recent advances in drug delivery to the eye
- Provides an overview of the regulatory framework around ophthalmic dosage forms






Reviews
There are no reviews yet.